Jefferies Upgrades Inovio Pharmaceuticals (INO) to Buy

August 13, 2026 4:37 AM

Jefferies analyst Roger Song upgraded Inovio Pharmaceuticals (NASDAQ: INO) from Hold to Buy with a price target of $3.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found